Therapeutic potential for CD39 in renal transplantation: there is hope.
Laubach
V E
VE
D000241:Adenosine / Q000627:therapeutic use; D015703:Antigens, CD / Q000627:therapeutic use*; D001081:Apyrase / Q000627:therapeutic use*; D051799:Delayed Graft Function / Q000209:etiology; D006801:Humans; D016030:Kidney Transplantation; D043705:Receptor, Adenosine A2A / Q000502:physiology; D015427:Reperfusion Injury / Q000150:complications / Q000517:prevention & control*; D014181:Transplantation Immunology
D015703:Antigens, CD; D043705:Receptor, Adenosine A2A; D001081:Apyrase; C067869:CD39 antigen; D000241:Adenosine